TrialEpilepsia2025

Long-term efficacy and safety of cannabidiol in patients with treatment-resistant focal epilepsies treated in the Expanded Access Program.

Anup D Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.